URGNUroGen Pharma Ltd.

$45.91

Who owns URGN

171 institutions reported holding URGN for 2026Q1, together 93% of the company, more than the 165 a quarter earlier.

171

Institutions reporting a position · as of 2026Q1 · up from 165 the quarter before

Shares held by institutions
46.4M

Shares held by institutions · 93% of the company · long US equity positions only, as reported on Form 13F

Reported value
$835M

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
30%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
36
New positions
28
Positions exited
27
Added to
48
Reduced
46
Top 10 holdersof the company
47%
Institutional ownership by quarter, 2017Q2 to 2026Q1
QuarterFilersSharesReported value
2026Q117146.4M$835M
2025Q416543.7M$1.02B
2025Q315944.0M$891M
2025Q214939.8M$545M
2025Q113941.6M$461M
2024Q413736.3M$386M
2024Q312735.1M$446M
2024Q211438.2M$641M
2024Q111227.2M$407M
2023Q410421.4M$321M
2023Q310017.7M$248M
2023Q28513.2M$137M
2023Q16512.5M$116M
2022Q46413.0M$115M
2022Q36013.3M$111M
2022Q26513.4M$109M
Largest reported holders, 2026Q1
HolderShares% of companyValue
RTW INVESTMENTS, LP4.5M9.1%$82M
BlackRock Inc.2.8M5.7%$51M
TORONTO DOMINION BANK2.6M5.2%$47M
MORGAN STANLEY2.6M5.1%$46M
Kynam Capital Management, LP2.2M4.5%$40M
Jefferies Group LLC2.2M4.4%$40M
Paradigm Biocapital Advisors LP1.7M3.4%$31M
ACORN CAPITAL ADVISORS, LLC1.7M3.3%$30M
SG Americas Securities, LLC1.7M3.3%$30M
AMERICAN CENTURY COMPANIES INC1.6M3.3%$29M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…